AbbVievsAbbott Laboratories

ABBV and ABT stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$109.11

Value $190B

+0.54%
ABT's page

AbbVie (ABBV) has a market value of $527B and Abbott Laboratories (ABT) $190B. The P/E is 51.2 for ABBV and 40.3 for ABT. Dividend yield: ABBV 2.32%, ABT 2.31%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$527B

    ABT$190B

    ABBV is 2.8 times ABT

  • Revenue, 12 months

    ABBV$66.0B

    ABT$48.2B

    ABBV is 1.4 times ABT

  • Net income, 12 months

    ABBV$10.3B

    ABT$4.7B

    ABBV is 2.2 times ABT

  • Operating margin

    ABBV32.2%

    ABT13.8%

    18.4 points apart

  • ROIC

    ABBV25.7%

    ABT6.3%

    19.4 points apart

  • P/E

    ABBV51.2

    ABT40.3

    ABBV is 1.3 times ABT

  • Dividend yield

    ABBV2.3%

    ABT2.3%

    About the same

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

Prices are not available right now.

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieABTAbbott Laboratories

Valuation

ABBVABT
Valuation
Price$298.12$109.11
Market value$527B$190B
Enterprise value (EV)$597B$216B
P/E51.240.3
P/E, 5-year median57.033.7
P/B–3.7
EV/EBIT28.132.6
Free cash flow yield3.6%3.6%

Results and growth

ABBVABT
Results and growth
Revenue, 12 months$66.0B$48.2B
Net income, 12 months$10.3B$4.7B
Free cash flow, 12 months$18.9B$6.8B
Earnings per share, 12 months$5.81$2.69
Revenue growth, year on year8.6%5.7%
Revenue growth a year, past+5.9%over 5 years+5.1%over 5 years
EPS growth a year, past-2.8%over 5 years+8.3%over 5 years

Margins and returns on capital

ABBVABT
Margins and returns on capital
Gross margin73.7%56.9%
Operating margin32.2%13.8%
Net margin15.7%9.8%
ROIC25.7%6.3%
ROE–9.1%

Balance sheet

ABBVABT
Balance sheet
Cash$10.8B$4.3B
Total debt$80.9B$31.2B
Net debt / EBITDA3.23.3
Interest cover7.1×6.7×

Dividends and buybacks

ABBVABT
Dividends and buybacks
Dividend yield2.3%2.3%
Dividend per share, 12 months$6.92$2.52
Dividend growth a year, past+6.6%over 5 years+10.4%over 5 years
Buyback yield0.2%0.5%
Shareholder yield2.5%2.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or ABT

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or Abbott Laboratories?

By market value, AbbVie ($527B) is about 2.8 times Abbott Laboratories ($190B), at today's prices.

Which pays the higher dividend, ABBV or ABT?

The dividend yield at today's price is 2.32% for AbbVie and 2.31% for Abbott Laboratories. Over the last twelve months they paid $6.92 and $2.52 per share.

What is the P/E of ABBV and ABT?

At today's price, the P/E is 51.2 for ABBV and 40.3 for ABT. The median of the last five years was 57.0 and 33.7, which shows where each stands against its own past.

Which has the higher profit margins, AbbVie or Abbott Laboratories?

Over the last twelve months, the net margin was 15.7% for AbbVie and 9.8% for Abbott Laboratories, and the operating margin 32.2% and 13.8%. Revenue was $66.0B and $48.2B.

Which is the better investment, AbbVie or Abbott Laboratories?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.